tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Summit Therapeutics Reports Positive Phase III Trial Results
PremiumCompany AnnouncementsSummit Therapeutics Reports Positive Phase III Trial Results
23d ago
Akeso to announces results from OS analysis of Phase III HARMONi-A study
Premium
The Fly
Akeso to announces results from OS analysis of Phase III HARMONi-A study
1M ago
Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See
Premium
Stock Analysis & Ideas
Insiders Are Snapping Up These 2 Stocks — and Analysts Like What They See
1M ago
Buy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
PremiumRatingsBuy Rating for Summit Therapeutics Driven by Promising HARMONi-6 Trial Results and Improved Safety Profile
1M ago
Summit Therapeutics jumps after CAO buys $500,000 shares
Premium
The Fly
Summit Therapeutics jumps after CAO buys $500,000 shares
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Summit Therapeutics price target raised to $16 from $13 at Barclays
PremiumThe FlySummit Therapeutics price target raised to $16 from $13 at Barclays
1M ago
Summit Therapeutics Advances Ivonescimab Development Amid Financial Growth
Premium
Company Announcements
Summit Therapeutics Advances Ivonescimab Development Amid Financial Growth
1M ago
Summit Therapeutics Launches New Phase III Study
Premium
Company Announcements
Summit Therapeutics Launches New Phase III Study
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100